In line with previous findings, eritoran and anti-CD14 mostly inhibited Gram-negative-induced inflammation, whereas Gram-positive inflammation was more complement dependent, possibly explaining the lack of effects of eritoran in a broad sepsis population. Here, CD14 is linked to Sepsis.